Progenesis logo

Progenesis Main Focus

Progenesis is a San Diego-based company founded in 2015 that develops and offers non-invasive genetic tests for patients on their family planning journey. We offer a variety of services that can be customized to meet the needs of every patient we serve. The Progenesis team is a motivated group of genetic specialists, researchers, laboratory professionals, and analysts who are passionate about improving our patients' lives. As pioneers in genetic screening technologies, our scientists are constantly pursuing research initiatives to advance our services and expand our understanding of human genetics.
Address: 4150 Regents Park Row Suite 245 La Jolla, CA 92037

Email: [email protected]
Phone: (858) 257-2122
Fax: (858) 469-8600

Avenir®

Carrier Screening for Inherited Disorders

Understanding Your Results

Your results from Avenir® testing are sent to your physician through our online portal, Revela®. Your personalized gene report will include:

  • Clinically relevant mutations detected
  • Details about function of mutated genes
  • Diseases associated with identified mutations
  • Evidence for pathogenicity
  • Additional resources (websites, scientific literature)

The information provided in your gene report can be overwhelming, so we are dedicated to supporting our patients through this process. Progenesis provides complimentary access to genetic counseling to help you understand your results and continue on your family planning journey.

Next Steps

We understand that a positive result is an added stress for your family. If you find that you and/or your partner is a carrier of a genetic condition, there are many options available to you. In vitro fertilization (IVF) with preimplantation genetic diagnosis (PGD) is a common choice amongst couples who are at high risk of having an affected child. PGD is a test that screens embryos for a specific disorder prior to implantation. The test is designed to detect single mutations in the embryo based on the parents’ genetic report, allowing physicians to select an embryo that is free of the genetic defect. Learn more about our PGD test here.